|1.||van Neck, Johan W: 5 articles (10/2012 - 03/2008)|
|2.||Barritault, Denis: 5 articles (02/2011 - 12/2007)|
|3.||Tong, Miao: 4 articles (10/2012 - 03/2008)|
|4.||Hekking, Ineke M: 3 articles (10/2012 - 11/2009)|
|5.||Hovius, Steven E R: 3 articles (10/2012 - 11/2008)|
|6.||Tuk, Bastiaan: 3 articles (10/2012 - 11/2009)|
|7.||Barritault, D: 3 articles (09/2009 - 01/2007)|
|8.||Papy-Garcia, Dulce: 2 articles (02/2011 - 07/2010)|
|9.||Courty, José: 2 articles (07/2010 - 12/2007)|
|10.||Charef, Said: 2 articles (07/2010 - 12/2007)|
|1.||Wounds and Injuries (Trauma)
03/01/2008 - "These results raise the possibility of efficacy of RGTA OTR4120 in accelerating surgically cutaneous wound healing by enhancing the wound breaking strength and improving the microcirculation."
11/01/2009 - "The present study investigates the underlying mechanisms of the effects of OTR4120 treatment in improving the quality of cutaneous wound repair. "
11/01/2009 - "We previously demonstrated that OTR4120 treatment had a long-term effect on increasing breaking strength and vasodilation in healing rat full-thickness excisional wounds. "
03/01/2008 - "On days 14 and 79 after surgery, the wounds treated with RGTA OTR4120 gained skin strength 12% and 48% of the unwounded skin, respectively, and displayed a significantly increased gain in skin strength when compared with control animals. "
03/01/2008 - "After creation of the wounds, RGTA OTR4120 was applied. "
11/01/2009 - "Three months after wounding, the effects of OTR4120 treatment on vascularization and inflammation resolution were normalized, except for an improved neodermis. "
07/01/2011 - "OTR4120 treatment also reduced inflammation and increased angiogenesis. "
11/01/2009 - "We found that OTR4120 treatment stimulated inflammation resolution and increased neovascularization. "
11/01/2009 - "We conclude that OTR4120 is a potential matrix therapeutic agent that ensures the quality of normal cutaneous wound repair and may restore impaired wound healing characterized by deficient angiogenesis and prolonged inflammation."
10/01/2012 - "To examine the effect of OTR4120 treatment on wound heal-ing, the degree of ulceration, inflammation, angiogenesis, and collagen synthesis were evaluated. "
10/01/2012 - "Moreover, restoration of the ulcer biomechanical strength was significantly enhanced after OTR4120 treatment. "
10/01/2012 - "The effect of OTR4120 on healing of diabetic ulcers was investigated. "
05/01/2008 - "The RGTA OTR4120 was used in treating chronic and severe corneal dystrophies as well as corneal ulcers resistant to usual treatments. "
05/01/2008 - "[Pilot study of a new matrix therapy agent (RGTA OTR4120) in treatment-resistant corneal ulcers and corneal dystrophy]."
02/01/2011 - "Matrix therapy with RGTA OTR4120 improves healing time and quality in hairless rats with deep second-degree burns."
01/01/2007 - "OTR4120 enhanced healing in short- and long-term after burns, reducing the formation of fibrotic tissue, and then represents a potential agent to improve burned skin healing."
01/01/2007 - "The tissue-regenerating effect of RGTA OTR4120 was evaluated after 1-6 days and after 10 months in a rat skin burn model. "
|2.||Heparitin Sulfate (Heparan Sulfate)
|5.||Sulfates (Sulfates, Inorganic)